What the claim actually is
Spend twenty minutes in any TRT forum and you’ll hit the same phrase: “just run 500 IU HCG every other day.” Said with total confidence, like it’s a settled fact, like someone tested it and handed down a verdict. I wanted to know if that confidence was earned. So I went and read the actual papers behind the number, not the forum paraphrase of the paper, the paper. Here’s what I found, and here’s my honest read on whether the numbers people repeat deserve the authority they’re given.
My rating system, because a table full of jargon doesn’t tell you anything
I’m not going to hand you a regimen. I’m not qualified to and neither is anyone else writing an article. What I can do is grade each dosing claim on how much evidence actually backs it up, the way I’d grade a product against its marketing copy. Here’s how the claims shake out when you hold them to that standard.
| Dosing claim | Where the number came from | What it was actually tested against | My rating |
|---|---|---|---|
| 125, 250, 500 IU every other day preserve intratesticular testosterone on TRT | Coviello 2005 controlled study [2] | Direct testicular-fluid hormone measurement | Solid. This one earns its reputation. |
| 500 IU every other day preserves spermatogenesis on TRT | Hsieh 2013 clinical series [3] | Azoospermia and fathered children | Decent, but it’s a small uncontrolled series, so don’t oversell it |
| Low doses (down to 125 IU) restore testicular androgen activity | Amory 2008 dose-response [5] | Serum 17-hydroxyprogesterone as a marker | Strong. The mechanism checks out |
| Any HCG dose for weight loss | Diet-protocol marketing | Nothing valid | Fails. The FDA’s own label says so [1] |
| A single “correct” HCG dose for everyone | Internet repetition | Nothing | Fails. There’s no such thing |
The two rows at the bottom are the ones people skip past, and they’re the ones that matter most. There’s genuinely good evidence for low-dose HCG doing a narrow, specific job inside the testicle. There is zero evidence for a universal dose, and there’s actual negative evidence, straight from the drug’s label, against the weight-loss use. Keep that hierarchy in your head, because the specific numbers get more persuasive-sounding the deeper you go, and it’s easy to forget which claim they’re actually attached to.
Where it holds up: the 125 to 500 IU range has a real paper trail
I went looking for the source of the famous range and it wasn’t hard to find. It’s one study, from 2005, and it’s better designed than I expected.
Researchers gave healthy men enough testosterone to shut down their own gonadotropin signal, the message that tells the testes to keep working. Then they added HCG at 125, 250, or 500 international units every other day, or a placebo, and instead of guessing at results from blood work alone, they sampled testicular fluid directly. That’s the part that impressed me. Direct measurement, not a proxy.
The results were a clean dose-response, and this is where the actual numbers live. In the group getting testosterone plus placebo, intratesticular testosterone dropped by about 94 percent. In the group getting 500 IU of HCG every other day, it sat about 26 percent above the men’s own baseline. The lower doses fell in between [2]. That’s the entire origin story of the number you see quoted everywhere.
A follow-up analysis using serum 17-hydroxyprogesterone as a stand-in marker confirmed that even the lower end of the range, 125 and 250 IU every other day, restored testicular androgen activity in the same kind of suppressed men [5]. This is the detail I think gets lost the most in forum threads: the lower doses worked. More was not automatically better. The right dose is the one hitting the actual goal, not the biggest number on the label.
Then there’s the outcomes piece, which is where the number moves from “hormone level on a chart” to “thing that happened to real people.” A clinical series followed hypogonadal men on testosterone who were also taking 500 IU of HCG every other day. None of them went azoospermic over the follow-up, and nine out of twenty-six fathered children during treatment [3]. That’s a genuinely reassuring result. My one caveat: it’s a small, uncontrolled series, so I’m not grading it as high as the Coviello data. It corroborates. It doesn’t prove on its own.
Honest summary of this section: the 125-to-500 IU range isn’t a made-up tradition. It’s the exact set of doses one careful controlled trial tested, against a direct measurement of the thing it’s supposed to affect, with a corroborating real-world result at the top end. That’s about as good as this corner of medicine gets. What it doesn’t do is tell you which number in that range belongs to you.
Where it falls apart: the weight-loss version of this number
Here’s the part of my review where the product fails outright.
HCG-diet protocols, usually bundled with a brutal calorie restriction, borrow the same “500 IU” credibility from the fertility research and slap it on a completely different claim. The FDA’s own labeling says HCG hasn’t been shown to be effective adjunctive therapy for obesity, that there’s no substantial evidence it adds weight loss beyond what calorie cutting alone would do, that it doesn’t redistribute fat more attractively, and that it doesn’t ease the hunger of a starvation diet [1]. No dosing number saves an effect that isn’t there. If your protocol loses weight, it’s the near-starvation calories doing it, and the HCG dose is set dressing.
I want to flag how strange this is, because it’s the cleanest gotcha in the whole topic: it’s the same 500 IU. Rock solid for preserving testicular function. Worthless for fat loss. Same number, opposite verdict, because the verdict was never about the number. It’s about what you’re measuring it against.
Why no article, including this one, can hand you your dose
This is the part I have to be blunt about. Every figure above came out of a study population under tightly controlled conditions. Turning any of it into your own protocol needs information that no article, mine included, can supply.
The right dose depends on the goal, and preserving fertility while on testosterone, restarting a shut-down hormonal axis after stopping testosterone, and treating an approved medical condition are not the same job with the same number. It depends on whether HCG is running alongside testosterone or by itself. It depends on lab values tracked over time, since the entire point of these studies was watching a hormone respond, and your number isn’t the study’s average. And it depends on a clinician who can weigh all of that together, which is exactly the standard the Endocrine Society’s guidelines lay out for managing testosterone and fertility, given that testosterone therapy suppresses sperm production in the first place [4].
Put plainly: these studies give a prescriber a defensible starting range and a way to tell if it’s working. They do not give a reader a recipe. If you’re using the 125-to-500 IU figures for anything, use them as the fence posts marking where the evidence actually lives, then let a clinician find the spot inside those posts that fits your labs.
The one thing I’d actually flag as useful: dosing isn’t a “set it and forget it” number
Here’s my one real takeaway from all this reading, and it’s the angle most dosing threads completely skip. Every study that produced these figures worked by measuring a response and adjusting toward it. That’s the actual model. HCG isn’t a number you dial in once. The relevant question is always whether the dose in front of you is doing its job on your labs and symptoms, which turns dosing into an ongoing process, not a one-time decision.
That’s a job that benefits from actual infrastructure, not memory and vibes. Supervised providers in this space build for exactly that. FormBlends, for example, runs HCG through a clinician evaluation and licensed pharmacy dispensing, and pairs it with a tracker app for staying on top of a protocol over time, which lines up with the measure-and-adjust posture the research itself demands. I’m not endorsing a specific app here. I’m saying the data argues against treating your dose as a fixed setting, and the same logic holds no matter who’s dispensing it.
The verdict
If I’m grading this whole topic like I’d grade any product claim: the 125, 250, and 500 IU every-other-day figures for preserving testicular function on TRT earn a genuinely good score. They come from a controlled study with a direct endpoint, a clean dose-response, lower doses shown to actually do the job, and a corroborating outcomes series at 500 IU [2][3][5]. Any HCG dose sold for weight loss fails, flatly contradicted by the drug’s own FDA label [1]. And the idea of one universal correct dose doesn’t survive contact with the evidence at all, because the right number depends on your goal, your context, and labs only a clinician can read [4].
These numbers are real, and they’re worth knowing. What they are not is a protocol you can lift off this page and run yourself. They’re a map of where the good evidence sits. Handing that map to a prescriber is useful. Trying to navigate it alone isn’t.
The usual questions
Where do the 125, 250, and 500 IU HCG numbers actually come from?
One controlled study, published in 2005. Researchers gave gonadotropin-suppressed men HCG at 125, 250, or 500 IU every other day, or a placebo, and measured testosterone directly inside the testicle [2]. That’s the entire origin of the range you see quoted everywhere. It isn’t tradition or forum consensus, it’s the exact set of doses one trial chose to test against a direct testicular endpoint.
Is 500 IU the “correct” HCG dose just because it’s the number everyone repeats?
No, and this is my biggest pet peeve on the topic. 500 IU was simply the highest arm in that trial, and it produced the biggest intratesticular testosterone response, about 26 percent above baseline [2]. But the lower doses, 125 and 250 IU, still restored testicular androgen activity in the same suppressed men [5]. More isn’t automatically the target. The right dose is whichever one hits the actual goal, not the largest number on the page.
Why does the same 500 IU figure work for fertility but do nothing for weight loss?
Because a dose is only meaningful attached to a specific goal. For preserving testicular function on testosterone, 500 IU every other day has a measured hormone response plus a corroborating outcomes series where none of the men went azoospermic and nine of twenty-six fathered children [3]. For fat loss, the FDA-approved label states HCG hasn’t been shown to increase weight loss beyond calorie restriction alone [1]. No dose fixes an effect the drug doesn’t have.
Does the research support one universal HCG dose for everyone?
No. The right figure depends on the goal, on whether HCG is used with testosterone or alone, and on lab values tracked over time, which is exactly why a clinician has to weigh it rather than applying one number across the board [4]. The 125 to 500 IU range marks where the good evidence tends to sit, not a single point that fits every person reading this.
Why do people describe HCG dosing as an ongoing process instead of a one-time decision?
Because that’s literally how the underlying studies worked. They measured a response and adjusted the dose against it [2][5]. The question was never “what’s the number,” it was “is this dose doing what we need on this person’s labs.” That makes dosing a process of measurement and adjustment, not a setting you pick once and walk away from.
References
- U.S. Food and Drug Administration, Drugs@FDA: Pregnyl (chorionic gonadotropin), application 017692. FDA-approved prescription product; labeling states HCG has not been demonstrated effective adjunctive therapy for obesity and that there is no substantial evidence it increases weight loss, improves fat distribution, or reduces diet-related hunger. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017692
- Coviello AD, et al. “Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression.” J Clin Endocrinol Metab. 2005;90(5):2595-2602. PMID 15713727. Men received testosterone plus HCG at 125, 250, or 500 IU every other day, or placebo; placebo group’s intratesticular testosterone fell about 94 percent, the 500 IU group’s sat about 26 percent above baseline. https://pubmed.ncbi.nlm.nih.gov/15713727/
- Hsieh TC, et al. “Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy.” J Urol. 2013;189(2):647-650. PMID 23260550. Twenty-six hypogonadal men on testosterone plus 500 IU hCG every other day; none became azoospermic, and nine fathered children during treatment.
- Bhasin S, et al. “Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.” J Clin Endocrinol Metab. 2018;103(5):1715-1744. PMID 29562364. Recommends against starting testosterone in men planning fertility in the near term, reflecting that exogenous testosterone suppresses spermatogenesis; basis for clinician-managed dosing.
- Amory JK, Coviello AD, et al. “Serum 17-hydroxyprogesterone strongly correlates with intratesticular testosterone in gonadotropin-suppressed normal men receiving various dosages of human chorionic gonadotropin.” Fertil Steril. 2008;89(2):380-386. PMID 17462643. Dose-response confirming low-dose hCG (125, 250, 500 IU every other day) restores intratesticular androgen activity in gonadotropin-suppressed men.
- FDA, “Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act.” The 503A framework under which prescription HCG is compounded and dispensed for the off-label men’s-health use.
What is HCG actually used for in men, and how is it different from what women use it for?
In men, HCG is used almost entirely to support testosterone production and fertility, not weight loss. It mimics luteinizing hormone (LH), signaling the testes to produce testosterone and keep sperm production going. That makes it useful for men on testosterone replacement who want to preserve testicular function, and for men with secondary hypogonadism trying to restore their own hormone output. The weight-loss angle, still floating around certain corners of the internet, has no credible clinical backing whatsoever.
What dose range does the research actually report for HCG in men?
Most published protocols land somewhere between 250 IU every other day and 500 IU three times a week, depending on what’s being targeted. Fertility restoration studies sometimes push higher, up to 1,000 to 2,000 IU two or three times weekly, particularly when sperm production itself is the goal rather than testosterone alone. Lower doses tend to do fine for maintaining testicular size and function alongside TRT. The number that’s right for you depends on labs, symptoms, and what you’re actually trying to accomplish.
What side effects do men actually report with HCG use?
The most commonly reported ones are elevated estradiol, acne, and fluid retention, all downstream of the testosterone bump HCG drives. Since HCG stimulates testosterone production, some of that testosterone converts to estrogen, which can cause breast tissue sensitivity or mild gynecomastia in susceptible men. Mood shifts and testicular ache at the injection site show up occasionally too. Most of this is dose-dependent and tends to ease off when the dose gets adjusted down.
Is HCG safe for men, and what does responsible use actually look like?
HCG has a reasonable safety track record in men when it’s prescribed, dosed sensibly, and monitored with actual blood work. The risk mostly comes from unsupervised use, sketchy unregulated sources, or running doses higher than the labs justify. A compounding pharmacy route with physician oversight, like what FormBlends provides, keeps the sourcing accountable and ties the dosing to real test results instead of guesswork. No hormone protocol is risk-free, but the evidence suggests those risks are manageable under proper supervision.
Written by Mara Petrova, reporting fellow. Checking each figure against the cited source. Last reviewed June 2026.
For background only. Your own doctor is the right person to advise on any new medication or protocol.
